March 18, 2025 11:22 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'The controversial ruler died 300 years ago': Uddhav Thackeray questions row over Aurangzeb's tomb | Maha Kumbh showed unity in diversity: PM Modi in Parliament | Think twice before travelling outside US: Indians with H-1B, F-1 visas, green cards warned by immigration attorneys | Mamata Banerjee visits Furfura Sharif, slams Opposition for questioning her intent ahead of 2026 polls | Left, BJP call Mamata's Oxford University invitation fake PhD deja vu, TMC hits back | Violence breaks out in Nagpur over call to remove Aurangzeb's tomb, Fadnavis appeals for peace | Ballet dance between dragon, elephant is the only choice: China after Modi's 'positive' remarks in Lex Fridman podcast | PM Modi meets Tulsi Gabbard, discusses ways to enhance cooperation for tackling terrorism | Trump, Modi are focused on strengthening shared interests of India and US: Tulsi Gabbard | Orry in legal trouble for drinking at Katra hotel near Vaishno Devi pilgrimage site in Jammu and Kashmir

Biocon Biologics announces major leadership changes

Aug 05, 2023, at 04:34 am

Mumbai: Biocon Biologics Ltd made leadership changes on Friday, revealing the appointments of Rhonda Duffy as Chief Operating Officer (COO) and Sandeep Athalye as Chief Development Officer.

Infosys announces Kiran Mazumdar-Shaw's retirement from board

Mar 24, 2023, at 02:17 am

Mumbai: Infosys on Thursday announced that Kiran Mazumdar-Shaw, an Independent Director, has retired from its Board upon completion of her tenure on March 22, 2023.

Kotak Special Situations Fund invests Rs 1070 cr in bio-pharma firm Biocon

Feb 23, 2023, at 06:08 am

Kolkata/IBNS: Kotak Special Situations Fund (KSSF), managed by Kotak Investment Advisors Ltd (KIAL), Wednesday announced an investment of Rs 1,070 crore in Biocon Ltd (BL), according to an official statement.

Biocon Q2FY21 revenue at Rs 1,760 cr, up 10 pc

Oct 23, 2020, at 10:42 pm

Bengaluru/UNI: Biocon Ltd, an innovation-led global biopharmaceuticals company on Friday announced its consolidated financial results for the fiscal second quarter ended September 30, 2020.

Biocon Revenue moves up by 14 pc and stood at 1690 Cr in Q1FY21

Jul 24, 2020, at 10:00 pm

Bengaluru/UNI: Pharmaceutical major Biocon Ltd, has reported revenue of Rs 1,690 Crore, an increase by 14 per cent, during the Q1 Financial year 2020-21.

Close menu